|
TMEM106A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.10862446895044E-15 |
| Normal-vs-Stage2 |
4.13669998255983E-09 |
| Normal-vs-Stage3 |
1.99840144432528E-15 |
| Normal-vs-Stage4 |
1.89337434619574E-12 |
| Stage1-vs-Stage2 |
6.056000E-01 |
| Stage1-vs-Stage3 |
1.129610E-01 |
| Stage1-vs-Stage4 |
1.458610E-01 |
| Stage2-vs-Stage3 |
5.839000E-01 |
| Stage2-vs-Stage4 |
5.173800E-01 |
| Stage3-vs-Stage4 |
8.245400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-16 |
| Normal-vs-AfricanAmerican |
4.40820000502384E-08 |
| Normal-vs-Asian |
2.41880004914208E-09 |
| Caucasian-vs-AfricanAmerican |
9.766600E-01 |
| Caucasian-vs-Asian |
8.394200E-01 |
| AfricanAmerican-vs-Asian |
8.752800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62492241884138E-12 |
| Male-vs-Female |
2.861000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.73194791841524E-12 |
| Normal-vs-Age(41-60Yrs) |
4.21884749357559E-15 |
| Normal-vs-Age(61-80Yrs) |
1.65001345919791E-12 |
| Normal-vs-Age(81-100Yrs) |
1.963740E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.465400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.104400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.974000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.582000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.607200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.270600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.639800E-04 |
| Classical-VS-Follicular |
3.384600E-01 |
| Classical-VS-Other |
2.070800E-01 |
| Classical-VS-Normal |
1.62503344114384E-12 |
| Tall-VS-Follicular |
5.446400E-02 |
| Tall-VS-Other |
9.324200E-01 |
| Tall-VS-Normal |
1.62525548574877E-12 |
| Follicular-VS-Other |
4.771800E-01 |
| Follicular-VS-Normal |
5.68756153285221E-12 |
| Other-VS-Normal |
1.66851999999773E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.72528658026749E-13 |
| Normal-vs-N1 |
2.43693953905222E-13 |
| N0-vs-N1 |
3.920400E-02 |
|
|
